Target intelligence / Profile preview

T cell receptor alpha joining 41 (TRAJ41)

Target
TRAJ41
Molecular classification
T cell receptor gene segment, Immunoglobulin superfamily, Other
01

Overview

T cell receptor alpha joining 41 (TRAJ41) is a J (joining) gene segment in the T cell receptor (TCR) alpha locus. It encodes a portion of the joining region of the variable domain of TCR alpha chains. During T cell development in the thymus, TRAJ41 can be recombined with variable (V) segments and the constant (C) region to generate diverse T cell receptor alpha chain transcripts. This genetic rearrangement underpins the antigen specificity and repertoire diversity of TCRs, which are essential for adaptive immune recognition of peptide–MHC complexes on antigen presenting cells[1][2][3][4][5]. TRAJ41 does not encode a standalone protein; its contribution is limited to TCR gene assembly, and it is not considered a druggable or functional molecular target by itself. Additional notes: - TRAJ41 is part of a large cluster of J gene segments in the TCR alpha locus, each contributing to TCR diversity but not having a direct functional or disease role individually. - Confusion may arise when treating gene segments (like TRAJ41) as standalone molecular targets; functional targets are typically full TCR alpha or beta chains, not their V, D, or J segments. Overall, TRAJ41 is a gene segment, not a therapeutic target or standalone functional protein.

Other names
TRAJ41TCR J41T cell receptor alpha joining segment 41
02

Biological functions

Generation of T cell receptor alpha chain diversityAntigen recognition
03

Disease associations

Other

Beyond the preview

Go deeper on T cell receptor alpha joining 41 (TRAJ41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 41 (TRAJ41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call